Navigation Links
InVitria Expands Sales Team
Date:8/26/2008

Global Supplier of Animal Free Products for Biopharmaceutical, Cell Culture, Life Science Research and Diagnostics Industry Adds Seasoned Sales Professional to Help Rapidly Expanding Customer Base Improve Productivity,

Safety and Time to Market

FORT COLLINS, Colo., Aug. 26 /PRNewswire/ -- InVitria (http://www.invitria.com), a leading global supplier of animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry, today announced the addition of seasoned professional Ray Tritch to its expanding Sales Team. Mr. Tritch will work with customers throughout the Eastern United States.

"We are very excited to welcome Ray to our sales team," said InVitria President, Scott Deeter. "As our customer base expands, Ray will be vital in ensuring InVitria's core values of customer service, partnership and innovation remain at the forefront of everything we do."

Mr. Tritch will leverage his significant history of success with companies including Jackson Laboratories, Invitrogen (formerly Life Technologies) and Serologicals as he works with customers to help them achieve advantages in their operations, including mammalian cell culture, bacterial fermentation and biopharmaceutical formulation, as well as other applications.

"I couldn't be happier about this newest stage in my professional journey," said Mr. Tritch. "The array of animal free products I will have in my toolkit will enable me to provide innovative, cost efficient, time saving and safe solutions to both existing and future InVitria customers.

"For example, Cellastim, an albumin used to replace bovine albumin and human albumin as a cell culture ingredient and biopharmaceutical formulation excipient, has been shown to improve mammalian cell culture productivity by up to 50% when compared with other forms of albumin. Lacromin, a lacto transferrin, can be used as a cell culture ingredient to improve productivity and safety versus bovine and human transferrin. And Lysobac is a bacterial cell lysis agent that is more efficient and consistent compared to chicken lysozyme.

"These animal free products represent the future in this industry -- the 'holy grail' of ingredients for the cell culture market -- and I am extremely proud to represent them as a part of the InVitria team."

To learn more about InVitria's animal free products, please email info@invitria.com or call 1-800-916-8311. Ray Tritch can be contacted directly at RTritch@InVitria.com.

About InVitria (http://www.invitria.com)

InVitria has developed animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:

-- Cellastim -- An albumin used to replace bovine albumin and human albumin as a cell culture ingredient and biopharmaceutical formulation excipient. Cellastim has been shown to improve mammalian cell culture productivity by up to 50% when compared with other forms of albumin. Cellastim also has been an effective component in stem cell media.

-- Lacromin -- Lacromin has been shown to replace bovine transferrin and human transferrin in cell culture media. In addition, at higher inclusion levels, Lacromin is a strong growth promotant as a supplement for mammalian cell culture media.

-- Lysobac -- A bacterial cell lysis agent that is more efficient and more consistent compared to chicken lysozyme. Lysobac is used in bacterial fermentation to improve recombinant protein yields.

To learn more about InVitria, please e-mail info@invitria.com or call 1-800-916-8311.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
2. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
3. Hoya Vision Care Expands in Czech Republic
4. MicuRx Pharmaceuticals Selects Next-Generation Antibiotic Candidate Targeting MRSA and Expands Operation in China
5. GenVault Expands Scientific Advisory Board
6. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
7. Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
8. Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
9. SAFC Supply Solutions Expands Halal Offer in Flavors & Fragrances Product Line
10. PAREXEL Expands Global Clinical Logistics Capabilities
11. BioXcel Expands Its Capability in Business Analytics Support Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... ... May 23, 2016 , ... RoviSys, a ... based in Aurora, Ohio, has broken ground on a new building in Holly ... Park area, this new location solidifies a commitment to business in the region. ...
(Date:5/20/2016)... ... 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural cell ... treat the disease. Surviving Mesothelioma has just posted an article on the new study. ... based their mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces ...
Breaking Biology Technology:
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
Breaking Biology News(10 mins):